NFKB1 and hepatocellular carcinoma: Several signaling pathways are enrolled in chemotherapeutic resistance in HCC such as TNFα/NF-κB, Wnt/β-catenin, TGFβ, Ras/MEK/ERK, and JAK/STAT pathways [4].